Julian Baker
Affiliations
- at Prelude Therapeutics Inc (PRLD), 2025-06-13
- at Incyte Corp (INCY), 2025-06-12
- at Vtv Therapeutics Inc. (VTVT), 2025-06-12
- at Kiniksa Pharmaceuticals International Plc (KNSA), 2025-06-05
- at Denali Therapeutics Inc. (DNLI), 2025-06-05
- at Acadia Pharmaceuticals Inc (ACAD), 2025-06-02
- at Beigene Ltd. (ONC), 2025-05-22
- at Immunocore Holdings Plc (IMCR), 2025-05-19
- at Igm Biosciences Inc. (IGMS), 2025-04-02
- at Dbv Technologies S.a. (DBVT), 2025-03-31
- at Replimune Group Inc. (REPL), 2025-03-07
- at Sera Prognostics Inc. (SERA), 2025-02-14
- at Bicycle Therapeutics Plc (BCYC), 2025-01-06
- at Kala Bio Inc. (KALA), 2024-12-31
- at Kymera Therapeutics Inc. (KYMR), 2024-08-22
- at Kodiak Sciences Inc. (KOD), 2024-07-02
- at Madrigal Pharmaceuticals Inc. (MDGL), 2024-06-27
- at Entrada Therapeutics Inc. (TRDA), 2024-06-26
- at Tscan Therapeutics Inc. (TCRX), 2024-06-14
- Director, Other at Neurogene Inc. (NGNE), 2023-12-20
- Director, Other at Seagen Inc. (SGEN), 2023-12-18
- Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2023-11-24
- Other at Atreca Inc. (BCEL), 2023-10-23
- Large Shareholder, Director at Talis Biomedical Corp (TLIS), 2023-06-13
- Director at Aeglea Biotherapeutics Inc. (AGLE), 2021-06-10
- Director at Alexion Pharmaceuticals Inc. (ALXN), 2020-05-18
- Director at Zymeworks Inc. (ZYME), 2020-05-12
- Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
- Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
- Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
- Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
- Large Shareholder at Invitae Corp (NVTA), 2018-03-29
- Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
- Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
- Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
- Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
- Other at Xoma Corp (XOMA), 2015-07-23
- Other at Synageva Biopharma Corp (GEVA), 2015-06-23
- Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
- Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
- Large Shareholder at Pharmacyclics Inc (PCYC), 2012-02-14
- Large Shareholder at Diadexus Inc. (DDXS), 2012-02-01
- Large Shareholder at Adolor Corp (ADLR), 2012-01-03
- Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
- Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
- Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
- Large Shareholder at Allos Therapeutics Inc (ALTH), 2009-02-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| IDRA | $2.00 | 2,928,596 | $5,857,192.00 | 9,309,333 | 2016-10-07 | Filing |
| IDRA | $2.00 | 321,404 | $642,808.00 | 1,003,781 | 2016-10-07 | Filing |
| INCY | $62.59 | 90,179 | $5,644,024.06 | 19,757,285 | 2016-03-17 | Filing |
| INCY | $62.59 | 9,821 | $614,665.94 | 3,358,951 | 2016-03-17 | Filing |
| INCY | $61.38 | 127,964 | $7,854,148.80 | 19,667,106 | 2016-03-17 | Filing |
Insider Trading: Sales See All